Abstract
1. The effects of a new long-acting inhaled beta 2-adrenoceptor agonist aerosol formoterol (12 micrograms), on FEV1, and on methacholine-induced bronchoconstriction, were compared with those of terbutaline (250 micrograms) and placebo in 12 midly asthmatic subjects. 2. PC20, the concentration of methacholine needed to cause a 20% fall in baseline FEV1, was determined 2 and 5 h after formoterol, terbutaline and placebo on separate days. Baseline PC20 was determined on a different day. 3. Compared with terbutaline and placebo, formoterol hastened recovery from methacholine-induced bronchoconstriction, and significantly increased mean PC20 (by 2.2- and 2.9-fold at 2 and 5 h respectively). 4. Thus, formoterol has a protective effect against methacholine-induced bronchoconstriction which lasts for at least 5 h.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Britton J., Hanley S. P., Garrett H. V., Hadfield J. W., Tattersfield A. E. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax. 1988 Apr;43(4):300–305. doi: 10.1136/thx.43.4.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chung K. F., Snashall P. D. Effect of prior bronchoconstriction on the airway response to histamine in normal subjects. Thorax. 1984 Jan;39(1):40–45. doi: 10.1136/thx.39.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paterson J. W., Woolcock A. J., Shenfield G. M. Bronchodilator drugs. Am Rev Respir Dis. 1979 Nov;120(5):1149–1188. doi: 10.1164/arrd.1979.120.5.1149. [DOI] [PubMed] [Google Scholar]
- Salome C. M., Schoeffel R. E., Yan K., Woolcock A. J. Effect of aerosol fenoterol on the severity of bronchial hyperreactivity in patients with asthma. Thorax. 1983 Nov;38(11):854–858. doi: 10.1136/thx.38.11.854. [DOI] [PMC free article] [PubMed] [Google Scholar]